Wiley Bros. Aintree Capital, LLC Edwards Lifesciences Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 8,160 shares of EW stock, worth $565,406. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,160
Previous 4,664
74.96%
Holding current value
$565,406
Previous $307,000
96.74%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding EW
# of Institutions
1,383Shares Held
487MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$4.79 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.53 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$2.3 Billion0.46% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.79 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.03 Billion0.09% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $42.8B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...